Scientists explain how inhalable gene therapies are being developed to treat cystic fibrosis.

Looking ahead to the next 5–10 years, what will be the key disruptors and/or what can be improved upon in the pharma industry?

An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.

Why the ability to design therapeutics based on glycobiology will make a mark on pharma R&D.

Experts explain why these are two important areas to watch in the near future of pharma R&D.

Not all patients are able to reap the benefits of groundbreaking new therapeutics. The industry must do more.

Personalized medicine, digital therapeutics, and GLP-1s; experts tell us what areas are hot in pharma’s future.

Alcami experts discuss what’s needed to accelerate drug development.

How next-generation drug delivery and advanced automation are set to transform pharma’s future.